May possibly promote substandard and falsified medications made or distributed less than unregulated and most likely unsafe approaches, or controlled substances such as narcotics. Two B.C.-primarily based providers stirred up confusion and controversy Thursday once they announced they were being permitted to manufacture and market copyright.